Mednax, Inc. (MD) Social Stream
Mednax Inc (MD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MD.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 45 weeks, MD's average price target has gone up $5.43.
Over the past 50 weeks, MD's average upside potential has been -2.14%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MD's average broker recommendation rating improved by 0 over the prior 59 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MD as an investment opportunity.
- In the context of Healthcare stocks, Mednax Inc's upside potential (average analyst target price relative to current price) is higher than 55.3% of them.
- In terms of how Mednax Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 216.75% of that group.
- MD has a greater average analyst price target than 99.97% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, Mednax Inc's variance in analysts' estimates is lower than -6.05% of them.
Make investment decisions regarding MD using the data that counts. Try POWR Ratings for free.